Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice |
| |
Authors: | Gernot Riedel Paola Fadda Susan McKillop-Smith Roger G Pertwee Bettina Platt Lianne Robinson |
| |
Affiliation: | 1School of Medical Sciences, College of Life Sciences and Medicine, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, UK;2B.B. Brodie Department of Neuroscience and Center of Excellence ‘Neurobiology of Dependence’, University of Cagliari, Cittadella Universitaria Monserrato, Cagliari, Italy |
| |
Abstract: | Background and purpose:Obesity is a severe health problem in the modernized world and understanding the central nervous mechanisms underlying food-seeking behaviour and reward are at the forefront of medical research. Cannabinoid receptors have proven an efficient target to suppress hunger and weight gain by their pharmacological inactivation.Experimental approach:A standard fasted protocol and a novel long-term home-cage observation system with free-feeding animals were used to assess the feeding behaviour of mice treated with the CB1 antagonist AM251. Similarly, the effects of the phytocannabinoid Δ9-tetrahydrocannabivarin (Δ9-THCV), which behaves like a CB1 antagonist, were also determined in free-feeding animals.Key results:AM251 suppressed food intake and weight gain in fasted and non-fasted animals. The suppression of food intake by AM251 (10 mg·kg−1) endured for a period of 6–8 h when administered acutely, and was continuous when injected for four consecutive days. Pure Δ9-THCV also induced hypophagia and weight reduction at doses as low as 3 mg·kg−1. No rebound was observed on the following day with all drug groups returning to normal activity and feeding regimes. However, a Δ9-THCV-rich cannabis-extract failed to suppress food intake and weight gain, possibly due to residual Δ9-tetrahydrocannabinol (Δ9-THC) in the extract. This Δ9-THC effect was overcome by the co-administration of cannabidiol.Conclusions and implications:The data strongly suggest (i) the long-term home-cage observation system is a sensitive and obesity-relevant tool, and (ii) the phytocannabinoid Δ9-THCV is a novel compound with hypophagic properties and a potential treatment for obesity. |
| |
Keywords: | obesity hypophagia phytocannabinoids Δ9-THCV AM251 home cage mice CB1 receptor |
|
|